Development of retroviral vectors as safe, targeted gene delivery systems

The transfer of genes of potential therapeutic benefit is presently being attempted in the clinic to treat a number of genetic and virally induced diseases. Many of these protocols use retroviral vectors derived from murine leukemia retroviruses as gene delivery systems. Although these viral deliver...

Full description

Saved in:
Bibliographic Details
Published in:Journal of molecular medicine (Berlin, Germany) Germany), 1996-04, Vol.74 (4), p.171-182
Main Authors: GÜNZBURG, W. H, SALMONS, B
Format: Article
Language:English
Subjects:
Biological and medical sciences
Biotechnology
Fundamental and applied biological sciences. Psychology
Gene Transfer Techniques
Genetic engineering
Genetic technics
Genetic Therapy - methods
Genetic Vectors
Methods. Procedures. Technologies
Retroviridae - genetics
Vectors (cloning, transfer, expression). Insertion sequences and transposons
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c311t-f9d715cbecc2ff30e1bc5387ec7257faae68808d4fa017f06f6b64eed0b1791c3
cites
container_end_page 182
container_issue 4
container_start_page 171
container_title Journal of molecular medicine (Berlin, Germany)
container_volume 74
creator GÜNZBURG, W. H
SALMONS, B
description The transfer of genes of potential therapeutic benefit is presently being attempted in the clinic to treat a number of genetic and virally induced diseases. Many of these protocols use retroviral vectors derived from murine leukemia retroviruses as gene delivery systems. Although these viral delivery systems are well suited for this purpose, a number of their characteristics, some of which are discussed here, are still troublesome. Future retroviral vectors will incorporate nonretroviral features and will be tailored to desired needs for specific uses. These vectors will be safer, more efficient, and targeted in their delivery. Further, expression of the therapeutic genes carried will be limited to the specific target cell type. Some of the recent advances that have been made towards this goal are reviewed here.
doi_str_mv 10.1007/BF00204747
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78183131</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78183131</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-f9d715cbecc2ff30e1bc5387ec7257faae68808d4fa017f06f6b64eed0b1791c3</originalsourceid><addsrcrecordid>eNpFkMFLwzAUxoMoc04v3oUcxINYzWvSJD3qdDoYeNFzSdOXUWnXmWSF_fdWLJN3-A7fj4_Hj5BLYPfAmHp4WjCWMqGEOiJTEDxNQAh2TKYsFzJJFchTchbCF2OgslxMyEQrwaTQU7J8xh6bbtviJtLOUY_Rd33tTUN7tLHzgZpAg3F4R6Pxa4xY0TVukFbY1D36PQ37ELEN5-TEmSbgxZgz8rl4-Zi_Jav31-X8cZVYDhATl1cKMluitalznCGUNuNaoVVpppwxKLVmuhLODN86Jp0spUCsWAkqB8tn5OZvd-u77x2GWLR1sNg0ZoPdLhRKg-Yw3Izc_oHWdyF4dMXW163x-wJY8eut-Pc2wFfj6q5ssTqgo6ihvx57E6xpnDcbW4cDxkHkMpX8BwzudRw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78183131</pqid></control><display><type>article</type><title>Development of retroviral vectors as safe, targeted gene delivery systems</title><source>Springer Online Journal Archives (Through 1996)</source><creator>GÜNZBURG, W. H ; SALMONS, B</creator><creatorcontrib>GÜNZBURG, W. H ; SALMONS, B</creatorcontrib><description>The transfer of genes of potential therapeutic benefit is presently being attempted in the clinic to treat a number of genetic and virally induced diseases. Many of these protocols use retroviral vectors derived from murine leukemia retroviruses as gene delivery systems. Although these viral delivery systems are well suited for this purpose, a number of their characteristics, some of which are discussed here, are still troublesome. Future retroviral vectors will incorporate nonretroviral features and will be tailored to desired needs for specific uses. These vectors will be safer, more efficient, and targeted in their delivery. Further, expression of the therapeutic genes carried will be limited to the specific target cell type. Some of the recent advances that have been made towards this goal are reviewed here.</description><identifier>ISSN: 0946-2716</identifier><identifier>EISSN: 1432-1440</identifier><identifier>DOI: 10.1007/BF00204747</identifier><identifier>PMID: 8740648</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Biological and medical sciences ; Biotechnology ; Fundamental and applied biological sciences. Psychology ; Gene Transfer Techniques ; Genetic engineering ; Genetic technics ; Genetic Therapy - methods ; Genetic Vectors ; Methods. Procedures. Technologies ; Retroviridae - genetics ; Vectors (cloning, transfer, expression). Insertion sequences and transposons</subject><ispartof>Journal of molecular medicine (Berlin, Germany), 1996-04, Vol.74 (4), p.171-182</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-f9d715cbecc2ff30e1bc5387ec7257faae68808d4fa017f06f6b64eed0b1791c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23906,23907,25115,27898,27899</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3149626$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8740648$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GÜNZBURG, W. H</creatorcontrib><creatorcontrib>SALMONS, B</creatorcontrib><title>Development of retroviral vectors as safe, targeted gene delivery systems</title><title>Journal of molecular medicine (Berlin, Germany)</title><addtitle>J Mol Med (Berl)</addtitle><description>The transfer of genes of potential therapeutic benefit is presently being attempted in the clinic to treat a number of genetic and virally induced diseases. Many of these protocols use retroviral vectors derived from murine leukemia retroviruses as gene delivery systems. Although these viral delivery systems are well suited for this purpose, a number of their characteristics, some of which are discussed here, are still troublesome. Future retroviral vectors will incorporate nonretroviral features and will be tailored to desired needs for specific uses. These vectors will be safer, more efficient, and targeted in their delivery. Further, expression of the therapeutic genes carried will be limited to the specific target cell type. Some of the recent advances that have been made towards this goal are reviewed here.</description><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Transfer Techniques</subject><subject>Genetic engineering</subject><subject>Genetic technics</subject><subject>Genetic Therapy - methods</subject><subject>Genetic Vectors</subject><subject>Methods. Procedures. Technologies</subject><subject>Retroviridae - genetics</subject><subject>Vectors (cloning, transfer, expression). Insertion sequences and transposons</subject><issn>0946-2716</issn><issn>1432-1440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNpFkMFLwzAUxoMoc04v3oUcxINYzWvSJD3qdDoYeNFzSdOXUWnXmWSF_fdWLJN3-A7fj4_Hj5BLYPfAmHp4WjCWMqGEOiJTEDxNQAh2TKYsFzJJFchTchbCF2OgslxMyEQrwaTQU7J8xh6bbtviJtLOUY_Rd33tTUN7tLHzgZpAg3F4R6Pxa4xY0TVukFbY1D36PQ37ELEN5-TEmSbgxZgz8rl4-Zi_Jav31-X8cZVYDhATl1cKMluitalznCGUNuNaoVVpppwxKLVmuhLODN86Jp0spUCsWAkqB8tn5OZvd-u77x2GWLR1sNg0ZoPdLhRKg-Yw3Izc_oHWdyF4dMXW163x-wJY8eut-Pc2wFfj6q5ssTqgo6ihvx57E6xpnDcbW4cDxkHkMpX8BwzudRw</recordid><startdate>19960401</startdate><enddate>19960401</enddate><creator>GÜNZBURG, W. H</creator><creator>SALMONS, B</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960401</creationdate><title>Development of retroviral vectors as safe, targeted gene delivery systems</title><author>GÜNZBURG, W. H ; SALMONS, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-f9d715cbecc2ff30e1bc5387ec7257faae68808d4fa017f06f6b64eed0b1791c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Transfer Techniques</topic><topic>Genetic engineering</topic><topic>Genetic technics</topic><topic>Genetic Therapy - methods</topic><topic>Genetic Vectors</topic><topic>Methods. Procedures. Technologies</topic><topic>Retroviridae - genetics</topic><topic>Vectors (cloning, transfer, expression). Insertion sequences and transposons</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GÜNZBURG, W. H</creatorcontrib><creatorcontrib>SALMONS, B</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GÜNZBURG, W. H</au><au>SALMONS, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of retroviral vectors as safe, targeted gene delivery systems</atitle><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle><addtitle>J Mol Med (Berl)</addtitle><date>1996-04-01</date><risdate>1996</risdate><volume>74</volume><issue>4</issue><spage>171</spage><epage>182</epage><pages>171-182</pages><issn>0946-2716</issn><eissn>1432-1440</eissn><abstract>The transfer of genes of potential therapeutic benefit is presently being attempted in the clinic to treat a number of genetic and virally induced diseases. Many of these protocols use retroviral vectors derived from murine leukemia retroviruses as gene delivery systems. Although these viral delivery systems are well suited for this purpose, a number of their characteristics, some of which are discussed here, are still troublesome. Future retroviral vectors will incorporate nonretroviral features and will be tailored to desired needs for specific uses. These vectors will be safer, more efficient, and targeted in their delivery. Further, expression of the therapeutic genes carried will be limited to the specific target cell type. Some of the recent advances that have been made towards this goal are reviewed here.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>8740648</pmid><doi>10.1007/BF00204747</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0946-2716
ispartof Journal of molecular medicine (Berlin, Germany), 1996-04, Vol.74 (4), p.171-182
issn 0946-2716
1432-1440
language eng
recordid cdi_proquest_miscellaneous_78183131
source Springer Online Journal Archives (Through 1996)
subjects Biological and medical sciences
Biotechnology
Fundamental and applied biological sciences. Psychology
Gene Transfer Techniques
Genetic engineering
Genetic technics
Genetic Therapy - methods
Genetic Vectors
Methods. Procedures. Technologies
Retroviridae - genetics
Vectors (cloning, transfer, expression). Insertion sequences and transposons
title Development of retroviral vectors as safe, targeted gene delivery systems
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-04T11%3A57%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20retroviral%20vectors%20as%20safe,%20targeted%20gene%20delivery%20systems&rft.jtitle=Journal%20of%20molecular%20medicine%20(Berlin,%20Germany)&rft.au=G%C3%9CNZBURG,%20W.%20H&rft.date=1996-04-01&rft.volume=74&rft.issue=4&rft.spage=171&rft.epage=182&rft.pages=171-182&rft.issn=0946-2716&rft.eissn=1432-1440&rft_id=info:doi/10.1007/BF00204747&rft_dat=%3Cproquest_cross%3E78183131%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c311t-f9d715cbecc2ff30e1bc5387ec7257faae68808d4fa017f06f6b64eed0b1791c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78183131&rft_id=info:pmid/8740648&rfr_iscdi=true